U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

TRIPTERYGIUM REGELII WHOLE

MORE DETAILS

1LJB9A0E2F

structurally diverse
Status:
Other
Class:
STRUCTURALLY DIVERSE

TRIPTERYGIUM WILFORDII WHOLE

MORE DETAILS

GBE347P41D

structurally diverse
Status:
Possibly Marketed Outside US
Source:
NCT03589833: Phase 4 Interventional Completed Arthritis, Rheumatoid
(2019)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT03589833
First approved in 2013
Source:
PAMO Kill Natural by GeoRim Pharmaceutical
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=655270c0-3e00-4f81-8d18-611fac91c8ca
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966